NAN
Nanosonics Ltd.
Healthcare Equipment and Supplies
·
Healthcare
20
comments
10
fund managers
past 90 days
About Nanosonics Ltd.
Nanosonics Ltd. develops and commercializes infection control and decontamination technologies. Headquartered in Sydney, Australia, and founded in 2000, the company provides automated ultrasound probe disinfection systems, including the trophon EPR, trophon technology, and trophon2. Nanosonics operates globally across three primary geographic segments: North America, Europe and the Middle East, and Asia Pacific. The firm focuses on the research and development of clinical solutions to improve infection prevention standards in healthcare environments.
Commentary Volume
20
Comments
10
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$1B
Fund managers
10 managers
First covered
31 Mar 2024
Last updated
24 Apr 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Nanosonics Ltd. (ASX:NAN)
Frequently asked questions
Who is investing in Nanosonics Ltd. (ASX:NAN)?
Fund managers including Longwave Capital, Forager Funds, Yarra Capital Management, Elston Asset Management, Lakehouse Capital, Selector Funds Management, Tyndall Asset Management, Hayborough Investment Partners, Investors Mutual Limited and ECP Asset Management have invested in Nanosonics Ltd. (ASX:NAN).
What is the short interest in Nanosonics Ltd. (ASX:NAN)?
The short interest in Nanosonics Ltd. (ASX:NAN) is 9.12% which makes it the 16th most shorted stock on the ASX. Of the 303.3M shares that Nanosonics Ltd. has on issue, 27.7M have been sold short.
What does Nanosonics Ltd. (ASX:NAN) do?
Nanosonics Ltd. develops and commercializes infection control and decontamination technologies. Headquartered in Sydney, Australia, and founded in 2000, the company provides automated ultrasound probe disinfection systems, including the trophon EPR, trophon technology, and trophon2. Nanosonics operates globally across three primary geographic segments: North America, Europe and the Middle East, and Asia Pacific. The firm focuses on the research and development of clinical solutions to improve infection prevention standards in healthcare environments.
Loading...